Table 3.
Summary of lncRNA-miRNA-mRNA interactions in HepG2 and SNU449 cells at 24 hours of Sorafenib treatment
|
lncRNA
|
miRNA
|
mRNA
|
Condition
|
| MIR4435-2HG | hsa-miR-3187-3p | ATOH8 | HepG2 24 hours |
| MALAT1 | hsa-miR-769-5p | FAXDC2 | |
| ZFAS1 | hsa-miR-193b-3p | SIAH1 | |
| THAP9-AS1 | hsa-miR-374b-3p | SMAD7 | |
| MALAT1 | hsa-miR-374b-3p | ||
| MALAT1 | hsa-miR-769-5p | TFAP4 | |
| SNHG17 | hsa-miR-769-5p | ||
| MALAT1 | hsa-miR-374b-3p | TIPARP | |
| SNHG12 | hsa-let-7b-5p | ADRB2 | SNU449 24 hours |
| EPB41 L4A-AS1 | hsa-miR-195-5p | ||
| PVT1 | hsa-miR-195-5p | ||
| LINC01578 | hsa-miR-195-5p | ||
| GAS5 | hsa-miR-374c-5p | CEBPB | |
| SNHG5 | hsa-miR-374c-5p | ||
| SNHG7 | hsa-miR-34a-5p | KLF4 | |
| EPB41 L4A-AS1 | hsa-miR-195-5p | VEGFA | |
| PVT1 | hsa-miR-195-5p | ||
| LINC01578 | hsa-miR-195-5p | ||
| GAS5 | hsa-miR-374c-5p | ||
| SNHG5 | hsa-miR-374c-5p |